A carregar...
Effect of background long-acting beta(2)-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
BACKGROUND: Phase III studies demonstrated efficacy and safety of nebulized glycopyrrolate inhalation solution (GLY) in subjects with COPD. Secondary analyses were performed to examine the effect of background long-acting beta(2)-agonist (LABA) use on the efficacy and safety of nebulized GLY. METHOD...
Na minha lista:
| Publicado no: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6157543/ https://ncbi.nlm.nih.gov/pubmed/30275690 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S172408 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|